Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin α Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects1
Open Access
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 64 (4) , 1122-1130
- https://doi.org/10.1095/biolreprod64.4.1122
Abstract
We previously reported formation of ovarian granulosa cell tumors with 100% penetration in a transgenic mouse model with murine inhibin α subunit promoter-driven (inhα)/Simian Virus 40 T-antigen (Tag). The tumor-bearing inhα/Tag mice showed highly elevated serum levels of immunoreactive inhibin. To investigate the onset of tumorigenesis and related endocrine consequences, 6–8 female mice of two inhα/Tag lines and their mating control littermates were killed monthly between 1 and 6 mo of age. We also investigated tumorigenesis-related fertility aspects of these two mouse lines. The ontogeny and progression of tumors could be monitored in both inhα/Tag lines by alterations of ovarian weights and serum hormone levels. Serum progesterone levels increased in both inhα/Tag lines in an age-dependent manner as ovarian tumorigenesis progressed, and a reciprocal decrease occurred in serum LH and FSH. Neither serum estradiol (E2) nor uterine weights were significantly altered during tumorigenesis, suggesting that the ovarian tumors represented late stages of granulosa cell differentiation. In conclusion, the present findings show in the inhα/Tag TG mice a relation between endocrine consequences of granulosa cell tumorigenesis, and a connection of onset of tumor formation with aberrant steroidogenesis and gonadotropin secretion. These findings indicate that tumors are endocrinologically active and able to exert enhanced negative feedback effects on pituitary function. The tumors provide a good model for endocrinologically active hormone-dependent tumors.Keywords
This publication has 37 references indexed in Scilit:
- Review of the granulosa-theca cell tumors from the Emil Novak Ovarian Tumor RegistryAmerican Journal of Obstetrics and Gynecology, 1999
- Granulosa cell tumours of the ovary: Demographics, survival and the management of advanced diseaseClinical Oncology, 1998
- Inhibin as a marker for ovarian cancerBritish Journal of Cancer, 1995
- Ovarian carcinoma serum markers and ovarian steroid activity — is there a link in ovarian cancer? A correlation of inhibin, tetranectin and CA-125 to ovarian activity and the gonadotropin levelsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
- A Prospective Study of Inhibin in Granulosa Cell Tumors of the OvaryGynecologic Oncology, 1994
- Granulosa Cell Tumors of the Ovary: Prognostic Factors and OutcomeGynecologic Oncology, 1994
- α-lnhibin is a tumour-suppressor gene with gonadal specificity in miceNature, 1992
- Inhibin as a Marker for Granulosa-Cell TumorsNew England Journal of Medicine, 1989
- Cyclophosphamide, adriamycin, and cis-platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor markerGynecologic Oncology, 1986
- Juvenile granulosa cell tumor of the ovaryThe American Journal of Surgical Pathology, 1984